March 07, 2025CorporateUltimaster Nagomi™ and Ultimaster™ Tansei™ are now MDR certified for patients at high bleeding risk
February 27, 2025CorporateTerumo and Daiichi Sankyo partner to support cardiovascular care in Vietnam
February 25, 2025CorporateNational Alliance of Sickle Cell Centers and Terumo Blood and Cell Technologies Working Together to Improve Outcomes for Patients with Sickle Cell DiseaseThe BET on Blood for SCD collaboration aims to improve the lives of Sickle Cell Warriors by connecting healthcare providers with education about proven treatments to help manage the disease
Refining Searches 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 Corporate Financial May 08, 2015 Financial Notice Regarding Dividend for the Fiscal Year Ended March 31, 2015 (PDF 17.43 KB) April 23, 2015 Corporate Notice Concerning Partial Amendment of the Articles of Incorporation (PDF 67.5 KB) April 23, 2015 Corporate Notice Concerning Transition to a Company with an Audit/Supervisory Committee (PDF 81.2 KB) April 17, 2015 Corporate Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant by U.S. Food & Drug Administration (FDA) April 10, 2015 Corporate Daiichi Sankyo and Terumo Announce Application in Japan for Manufacturing and Sales Approval of Intradermal Seasonal Influenza Vaccine April 06, 2015 Corporate Terumo and Olympus Expand Interventional System Business Partnership in the U.S. to Cover Urology and Gastroenterology March 27, 2015 Corporate FAMHP advises patients to not suspend nor stop any treatments March 23, 2015 Corporate Terumo Europe responds to broadcast EenVandaag Injection needles pose no health risks for patients February 12, 2015 Corporate Terumo Establishes a New R&D Center for Interventional Business in Southern California, US to Accelerate Worldwide Growth of Interventional Therapeutic Area February 03, 2015 Financial Notice Concerning Acquisition of the Company's Own Shares (Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 73.77 KB) Pagination Previous page ‹ Page1 … Page8 Page9 Current page10 Next page ›
May 08, 2015 Financial Notice Regarding Dividend for the Fiscal Year Ended March 31, 2015 (PDF 17.43 KB)
April 23, 2015 Corporate Notice Concerning Partial Amendment of the Articles of Incorporation (PDF 67.5 KB)
April 23, 2015 Corporate Notice Concerning Transition to a Company with an Audit/Supervisory Committee (PDF 81.2 KB)
April 17, 2015 Corporate Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant by U.S. Food & Drug Administration (FDA)
April 10, 2015 Corporate Daiichi Sankyo and Terumo Announce Application in Japan for Manufacturing and Sales Approval of Intradermal Seasonal Influenza Vaccine
April 06, 2015 Corporate Terumo and Olympus Expand Interventional System Business Partnership in the U.S. to Cover Urology and Gastroenterology
March 23, 2015 Corporate Terumo Europe responds to broadcast EenVandaag Injection needles pose no health risks for patients
February 12, 2015 Corporate Terumo Establishes a New R&D Center for Interventional Business in Southern California, US to Accelerate Worldwide Growth of Interventional Therapeutic Area
February 03, 2015 Financial Notice Concerning Acquisition of the Company's Own Shares (Acquisition of the company's own shares pursuant to item 2 of Article 165 of the Corporate Law concerning the provisions of the articles of incorporation) (PDF 73.77 KB)
Top
Top